Humaid Al-Shamsi, The Chairman of Nexomic, CEO of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared on LinkedIn:
“At Nexomic, We Don’t Just Study Cancer. We Understand Its Biology.
We are proud to announce 5 scientific abstracts presented by the Nexomic team at ESMO 2026, reflecting our commitment to advancing precision oncology through cutting-edge AI, multi-omics, and cancer biology.
Our abstracts will soon be available at Nexomic website.
Thank you to my dear co-founders Mohammad J. Ghosheh, Ghadeer Ghosheh for all your commitment and dedication.
A special thank you to ESMO for an outstanding scientific platform!
Next Stop: ESMO AI, Berlin! And we are just getting started!
We look forward to presenting 10 additional scientific abstracts, including an oral presentation, at ESMO AI next month.
15 abstracts. 2 major international conferences. One mission: Transforming cancer care through AI-driven precision oncology.”
Other articles from Nexomic on OncoDaily.
